Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of July 2, 2026, LLY trades at $1,211.75 with a market cap of $1.07T and a P/E ratio of 52.62. LLY moved +1.05% today. Year to date, LLY is +10.31%; over the trailing twelve months it is +53.59%. Its 52-week range spans $623.78 to $1,238.00. Analyst consensus is strong buy with an average price target of $1,290.79. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Eli Lilly (LLY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LLY moved +1.05% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $1,211.75 |
| Market Cap | $1.07T |
| P/E Ratio | 52.62 |
| EPS | $23.00 |
| Dividend Yield | 1.73% |
| 52-Week High | $1,238.00 |
| 52-Week Low | $623.78 |
| Volume | 2.26M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.18B |
| Net Income | $20.64B |
| Gross Margin | 83.04% |
22 analysts cover LLY: 0 strong buy, 20 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,290.79.